Literature DB >> 28692407

Overdose history is associated with postdetoxification treatment preference for persons with opioid use disorder.

Michael D Stein1,2, Jessica N Flori1, Megan M Risi1, Micah T Conti1, Bradley J Anderson1, Genie L Bailey2,3.   

Abstract

BACKGROUND: Without aftercare treatment, persons discharged from short-term inpatient detoxification for opioid use disorder are at high risk of relapse. In previous work, those who were recently homeless or had pending legal problems were more likely to prefer residential treatment for aftercare. Here, based on clinical experience, the authors hypothesize that a particular clinical factor, surviving an opioid overdose, will be associated with aftercare preference.
METHODS: Between May and December 2015, the authors surveyed consecutive persons seeking inpatient opioid detoxification. To assess aftercare treatment preference, participants were asked, "If you had unlimited treatment options and all were free, which one would work best for you when you leave here?" To assess overdose history, participants were asked about overdose "since your first drug use," and "in the last year."
RESULTS: Participants' (N = 440) mean age was 32.3 (± 8.7) years; 70.7% were male. More than half (51.1%) of participants expressed an aftercare preference for medication-assisted treatment (MAT), 12.7% for outpatient counseling only, 10.7% for residential treatment,18.6% for no formal treatment (Narcotics Anonymous/Alcoholics Anonymous only or a halfway house), and 6.8% did not want any postdetoxification treatment. About 40% reported a history of overdose, and 24.8% reported past year overdose. In the multivariate model, treatment preference was associated with sex (P < .001), homelessness (P = .01), and history of drug overdose (P = .02).
CONCLUSIONS: Although MAT was preferred by the majority of participants, the experience of a nonfatal overdose was associated with the choice of residential treatment as postdetoxification treatment.

Entities:  

Keywords:  Detoxification; opioids; overdose; residential treatment

Mesh:

Year:  2017        PMID: 28692407      PMCID: PMC6077990          DOI: 10.1080/08897077.2017.1353570

Source DB:  PubMed          Journal:  Subst Abus        ISSN: 0889-7077            Impact factor:   3.716


  22 in total

Review 1.  Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies.

Authors:  Louisa Degenhardt; Chiara Bucello; Bradley Mathers; Christina Briegleb; Hammad Ali; Matt Hickman; Jennifer McLaren
Journal:  Addiction       Date:  2010-11-04       Impact factor: 6.526

2.  Non-fatal heroin overdose, treatment exposure and client characteristics: findings from the Australian treatment outcome study (ATOS).

Authors:  Shane Darke; Anna Williamson; Joanne Ross; Maree Teesson
Journal:  Drug Alcohol Rev       Date:  2005-09

3.  Factors associated with frequent utilization of crisis substance use detoxification services.

Authors:  Emily Carrier; Jennifer McNeely; Iryna Lobach; Shane Tay; Marc N Gourevitch; Maria C Raven
Journal:  J Addict Dis       Date:  2011-04

4.  Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users.

Authors:  Thomas Kerr; Nadia Fairbairn; Mark Tyndall; David Marsh; Kathy Li; Julio Montaner; Evan Wood
Journal:  Drug Alcohol Depend       Date:  2006-09-07       Impact factor: 4.492

5.  Heroin-related overdose: The unexplored influences of markets, marketing and source-types in the United States.

Authors:  Sarah G Mars; Jason N Fessel; Philippe Bourgois; Fernando Montero; George Karandinos; Daniel Ciccarone
Journal:  Soc Sci Med       Date:  2015-06-30       Impact factor: 4.634

6.  The need for substance abuse after-care: longitudinal analysis of Oxford House.

Authors:  Leonard A Jason; Margaret I Davis; Joseph R Ferrari
Journal:  Addict Behav       Date:  2006-07-14       Impact factor: 3.913

7.  Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study.

Authors:  Marina Davoli; Anna M Bargagli; Carlo A Perucci; Patrizia Schifano; Valeria Belleudi; Matthew Hickman; Giuseppe Salamina; Roberto Diecidue; Federica Vigna-Taglianti; Fabrizio Faggiano
Journal:  Addiction       Date:  2007-12       Impact factor: 6.526

8.  Trends in inpatient detoxification services, 1992-1997.

Authors:  Tami L Mark; Joan D Dilonardo; Mady Chalk; Rosanna M Coffey
Journal:  J Subst Abuse Treat       Date:  2002-12

Review 9.  Heroin overdose: research and evidence-based intervention.

Authors:  Shane Darke; Wayne Hall
Journal:  J Urban Health       Date:  2003-06       Impact factor: 3.671

10.  Patients' Beliefs About Medications are Associated with Stated Preference for Methadone, Buprenorphine, Naltrexone, or no Medication-Assisted Therapy Following Inpatient Opioid Detoxification.

Authors:  Lisa A Uebelacker; Genie Bailey; Debra Herman; Bradley Anderson; Michael Stein
Journal:  J Subst Abuse Treat       Date:  2016-03-09
View more
  4 in total

1.  Population-level impact of initiating pharmacotherapy and linking to care people with opioid use disorder at inpatient medically managed withdrawal programs: an effectiveness and cost-effectiveness analysis.

Authors:  Alexandra Savinkina; Rajapaksha W M A Madushani; Golnaz Eftekhari Yazdi; Jianing Wang; Joshua A Barocas; Jake R Morgan; Sabrina A Assoumou; Alexander Y Walley; Benjamin P Linas; Sean M Murphy
Journal:  Addiction       Date:  2022-04-12       Impact factor: 7.256

2.  Letting the sun shine on patient voices: Perspectives about medications for opioid use disorder in Florida.

Authors:  Amanda Sharp; Melissa Carlson; Veronica Howell; Kathleen Moore; Zev Schuman-Olivier
Journal:  J Subst Abuse Treat       Date:  2020-12-11

3.  Association between mortality rates and medication and residential treatment after in-patient medically managed opioid withdrawal: a cohort analysis.

Authors:  Alexander Y Walley; Sara Lodi; Yijing Li; Dana Bernson; Hermik Babakhanlou-Chase; Thomas Land; Marc R Larochelle
Journal:  Addiction       Date:  2020-02-25       Impact factor: 6.526

4.  Touchpoints - Opportunities to predict and prevent opioid overdose: A cohort study.

Authors:  Marc R Larochelle; Ryan Bernstein; Dana Bernson; Thomas Land; Thomas J Stopka; Adam J Rose; Monica Bharel; Jane M Liebschutz; Alexander Y Walley
Journal:  Drug Alcohol Depend       Date:  2019-09-03       Impact factor: 4.492

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.